References
- Enright MC, McKenzie H. Moraxella (Branhamella) catarrhalis – clinical and molecular aspects of a rediscovered pathogen. J Med Microbiol 1997; 360–71.
- Ioannidis JP, Worthington M, Griffiths JK, Snydman DR. Spectrum and significance of bacteremia due to Moraxella catarrhalis. Clin Infect Dis 1995; 390–97
- Thorsson B, Haraldsdottir V, Kristjansson M. Moraxella catarrhalis bacteraemia. A report on 3 cases and a review of the literature. Scand J Infect Dis 1998; 105–09.
- Neumayer U, Schmidt HK, Mellwig KP, Kleikamp G. Moraxella catarrhalis endocarditis: report of a case and literature review. J Heart Valve Dis 1999; 114–7.
- Clyde WA. Mycoplasma pneumoniae respiratory disease symposium: summation and significance. Yale J Biol Med 1983; 523–7.
- Christensen JJ. Bacteraemia caused by a beta-lactamase producing strain of Branhamella catarrhalis: a case report. Acta Pathol Immunol Scand 1985; 93B: 273–5.
- Mundy PM. Implications for macrolide therapy in community-acquired pneumonia. Chest 1998; 113: 1201–6.
- Marston BJ. Incidence of community-acquired pneumonia requiring hospitalisation. Arch Intern Med 1997; 157: 1709–18.
- Clyde WA. Clinical overview of typical Mycoplasma pneumoniae infections. Clin Infect Dis 1993; 17: S32–6.
- Cimolai N, Wensley D, Seear M, Thomas ET. Mycoplasma pneumoniae as a cofactor in severe respiratory infections. Clin Infect Dis 1995; 1182–5.